Status:
COMPLETED
The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients
Lead Sponsor:
Rabin Medical Center
Conditions:
Hip Fractures
Clinical Pharmacists
Eligibility:
All Genders
65-120 years
Phase:
NA
Brief Summary
The influence of clinical pharmacist on various drug related outcomes was reported in different healthcare setting including the community, long term care and during acute hospitalization. Nevertheles...
Detailed Description
An Open label randomized prospective study of elderly patients (65 years old and above) admitted for rehabilitation after hip fracture. All study participants will be admitted in the same geriatric-re...
Eligibility Criteria
Inclusion
- Elderly patient (65 years of older) who were admitted for rehabilitation after hip fracture at "D" ward in beit rivka post-acute geriatric center.
Exclusion
- Patient that did not complete the rehabilitation period due the following causes: death, acute care hospitalization or severe medical deterioration.
- In the case of D2 sub unit hospitalized patient - any request by the sub unit medical or nursing staff for pharmacist consultation/intervention.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04360746
Start Date
March 1 2020
End Date
May 1 2022
Last Update
April 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beit Rivka geriatric rehabilitation center
Petah Tikva, Israel